Drugs for Neglected Diseases initiative (DNDi) 2017-2021 for the development of new effective treatments for neglected diseases and diseases with emerging resistance (360G-cabinetoffice-G2-GA-202112638245-21-22)
This programme in the Ross Fund Portfolio (which focusses on neglected tropical diseases, diseases of emerging resistance and diseases of epidemic potential) will support the development of new products (such as drugs, diagnostics and insecticides) for targeted diseases, including diseases of emerging resistance (that are becoming an increasing threat globally); neglected tropical diseases (that affect over a billion people worldwide); and diseases of epidemic potential (that can rapidly spread if not stopped).
Where is this data from?
This data was originally published by Cabinet Office. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Award Date | 2017-04-01T00:00:00+00:00 |
| Award type | Organisation |
| Managed by: Organisation Name | Foreign, Commonwealth & Development Office |
| Last Modified | 2023-02-02T00:00:00Z |
| From An Open Call? | No |
| Authority Act | International Development Act 2002 |
| Amount Awarded | 5300000 |
| Grant Programme: Code | G2-SCH-2021-12-9898 |
| Grant Programme: Title | Product Development Research programme (PDPs) |
| Allocation Method | General grants - Un-competed |
| Number of recipients | 1 |
| Recipient Org: Postal Code | 1202 |
| Recipient Org: Country | Switzerland |